EU MDR
EU MDR Vigilance Reporting and Field Safety Corrective Action – pharmaceutical compliance consulting
EU MDR Vigilance Reporting and Field Safety Corrective Action – pharmaceutical compliance consulting EU MDR Vigilance Reporting and Field Safety Corrective Action: A Step-by-Step Guide for Pharmaceutical Compliance Consulting The European Union Medical Device Regulation (EU MDR) introduces rigorous requirements for vigilance reporting and Field Safety Corrective Actions (FSCAs) that are crucial for pharmaceutical compliance consulting professionals. Understanding these requirements is essential for regulatory affairs, Quality Assurance (QA), and market access teams looking to ensure compliance and protect patient safety. This tutorial will provide a comprehensive, step-by-step guide to the key components of vigilance reporting and FSCAs within the framework…
Brexit and EU MDR: What’s Required for UK and EU Markets – pharma compliance consulting
Brexit and EU MDR: What’s Required for UK and EU Markets – pharma compliance consulting Brexit and EU MDR: What’s Required for UK and EU Markets The impact of Brexit on the regulatory landscape for Medical Devices and Combination Products has profoundly affected how pharmaceutical companies approach compliance consulting. Understanding the requirements under the EU Medical Device Regulation (MDR) post-Brexit is crucial for organizations seeking to navigate both the UK and EU markets. This comprehensive guide provides a structured approach to achieving compliance in this evolving regulatory environment. 1. Understanding the Transition from EU Regulations to UK Regulations Since the…
MDR Transition Deadlines: What Manufacturers Must Know – pharmaceutical compliance consulting
MDR Transition Deadlines: What Manufacturers Must Know – pharmaceutical compliance consulting MDR Transition Deadlines: What Manufacturers Must Know The transition to the Medical Device Regulation (MDR) 2017/745 in the European Union (EU) represents a significant shift in the regulatory framework governing medical devices and combination products. Manufacturers are required to understand the critical deadlines associated with this transition in order to ensure compliance. This guide serves as a comprehensive resource for stakeholders in the pharmaceutical compliance consulting field, regulatory affairs consulting firms, and medical technology companies navigating this complex landscape. Understanding the MDR Transition The European MDR, which came into…
MDR Requirements for Implantable and Class III Devices – regulatory affairs consulting firms
MDR Requirements for Implantable and Class III Devices – regulatory affairs consulting firms MDR Requirements for Implantable and Class III Devices Under EU MDR The European Union Medical Device Regulation (EU MDR) has brought significant changes to the regulation of medical devices, particularly concerning implantable and Class III devices. This article serves as an extensive guide tailored for regulatory affairs consulting firms, providing a detailed overview of the requirements for these devices under the new regulations. It is imperative for regulatory affairs professionals to understand these changes to ensure compliance and facilitate market access for products. Understanding the EU MDR…
Impact of MDR on Distributors, Importers, and Authorized Reps – regulatory affairs consulting services
Impact of MDR on Distributors, Importers, and Authorized Reps – regulatory affairs consulting services Impact of MDR on Distributors, Importers, and Authorized Reps under EU MDR The implementation of the Medical Device Regulation (MDR) has significantly altered the landscape of medical device distribution and market access in the EU. As a result, distributors, importers, and authorized representatives (ARs) must navigate this regulatory maze more diligently. This article serves as a detailed guide on the implications of MDR for these stakeholders, specifically focusing on their roles, obligations, and best practices in compliance. With the right regulatory affairs consulting services, organizations can…
EU MDR for IVD Devices (2022/746): How They Compare – regulatory affairs consulting companies
EU MDR for IVD Devices (2022/746): How They Compare – regulatory affairs consulting companies EU MDR for IVD Devices (2022/746): How They Compare The European Medical Device Regulation (EU MDR) 2017/745 and the In Vitro Diagnostic Regulation (IVDR) 2017/746 present new challenges and requirements for the regulation of IVD devices. Regulatory affairs consulting companies play a crucial role in navigating these complex frameworks. This article provides a comprehensive tutorial on EU MDR for IVD Devices (2022/746), focusing on approval pathways, technical documentation, post-market surveillance (PMS), and compliance actions. The aim is to ensure stakeholders in regulatory affairs can efficiently manage…
How to Prepare for a Notified Body Audit Under MDR – parexel pharmacovigilance
How to Prepare for a Notified Body Audit Under MDR – parexel pharmacovigilance How to Prepare for a Notified Body Audit Under MDR – parexel pharmacovigilance The Medical Device Regulation (MDR) lays down a comprehensive legislative framework that regulatory affairs professionals in the medical devices sector must navigate proficiently. A critical aspect of this process involves undergoing audits by Notified Bodies (NBs), which are essential for the certification and market access of medical devices within the European Union. This article serves as a step-by-step tutorial for stakeholders involved in parexel pharmacovigilance on how to prepare adequately for a Notified Body…
Advanced EU MDR Strategies for MedTech Regulatory Teams – regulatory affairs in pharmaceutical industry
Advanced EU MDR Strategies for MedTech Regulatory Teams – regulatory affairs in pharmaceutical industry Advanced EU MDR Strategies for MedTech Regulatory Teams The European Union Medical Device Regulation (EU MDR) has reshaped the landscape for regulatory affairs in the pharmaceutical industry, requiring a thorough understanding of its requirements. This article serves as a comprehensive tutorial for regulatory affairs professionals, focusing on advanced strategies associated with EU MDR compliance for MedTech products. Herein, we will provide detailed guidance on essential aspects including approval pathways, technical documentation, post-market surveillance (PMS), and compliance actions necessary for success in regulatory affairs within the pharmaceutical…
How to Build a EU MDR Compliance Tracker Dashboard – regulatory affairs in pharma industry
How to Build a EU MDR Compliance Tracker Dashboard – regulatory affairs in pharma industry How to Build a EU MDR Compliance Tracker Dashboard In the evolving landscape of regulatory requirements for medical devices and combination products, it is essential for stakeholders in regulatory affairs in the pharma industry to maintain compliance with the EU Medical Device Regulation (MDR). This comprehensive guide will lead you through the steps to build a EU MDR Compliance Tracker Dashboard. This dashboard will serve as a powerful visual tool to monitor compliance with the regulation, ultimately facilitating efficient decision-making, timely actions, and regulatory reporting….
Top KPIs for Monitoring EU MDR Performance and Timelines – pharmaceutical industry regulatory affairs
Top KPIs for Monitoring EU MDR Performance and Timelines – pharmaceutical industry regulatory affairs Top KPIs for Monitoring EU MDR Performance and Timelines As the landscape of medical device regulation continues to evolve, understanding the primary key performance indicators (KPIs) for monitoring European Medical Device Regulation (EU MDR) performance and timelines is crucial for stakeholders in pharmaceutical industry regulatory affairs. This article provides a comprehensive step-by-step guide for regulatory, quality assurance, and market access teams working within the pharmaceutical regulatory framework, focusing on EU MDR compliance. 1. Introduction to EU MDR and Its Significance The EU MDR, implemented in May…